HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of vaccinia virus poly(A) polymerase for RNA 3'-end labeling with a chain-terminating nucleotide or a short 3' homopolymer tract.

Abstract
Conditions are described for the 3'-end labeling of RNA with 32P 3'-dATP (3'-deoxyadenosine-5'-triphosphate), a chain-terminating nucleotide, using the poly(A) polymerase (PAP) encoded by vaccinia virus. Reaction time, divalent cation species and concentration, and the requirement for both subunits of the PAP were investigated. In the presence of Mn2+, vaccinia PAP is able to tail RNA primers with tracts of 3'-oligo(U), oligo(C) and oligo(G). Conditions for the addition of labeled 3'-homopolymer tracts were characterized. The use of low nucleotide concentrations in this study revealed an apparently fixed divalent cation concentration optimum of 0.1 mM, distinct from the previously noted requirement for a 1:1 divalent cation:NTP complex. This indicates a possible requirement for multiple divalent cations in nucleotidyl transfer by vaccinia PAP.
AuthorsJ G Thomson, P D Gershon
JournalBioTechniques (Biotechniques) Vol. 19 Issue 3 Pg. 416-20, 422-5 (Sep 1995) ISSN: 0736-6205 [Print] England
PMID7495555 (Publication Type: Research Support, Non-U.S. Gov't, Technical Report)
Chemical References
  • Cations, Divalent
  • Deoxyadenine Nucleotides
  • Deoxyadenosines
  • Phosphorus Radioisotopes
  • Manganese
  • RNA
  • Polynucleotide Adenylyltransferase
  • cordycepin
  • Magnesium
  • 2'-deoxyadenosine triphosphate
Topics
  • Cations, Divalent
  • Deoxyadenine Nucleotides (metabolism)
  • Deoxyadenosines
  • Gene Expression
  • Kinetics
  • Magnesium (pharmacology)
  • Manganese (pharmacology)
  • Phosphorus Radioisotopes
  • Polynucleotide Adenylyltransferase (genetics, metabolism)
  • RNA (metabolism)
  • Vaccinia virus (enzymology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: